ERBB2 and cancer: Although it cannot be definitively concluded that HER2 was transferred from the cancer cells to the CD14+ and CD56+ cells by trogocytosis, the observation is significant because HER2 expression is not usually observed on CD14+ and CD56+ cells in normal PBMCs (Additional file 2: Figures S2A and B).